Hepatocellular carcinoma - Insights
Hepatocellular carcinoma (HCC) is the third leading cause of death from cancer in the world. While HCC can be effectively treated in its early stages, most patients are not diagnosed until they are symptomatic and at higher grades and...
Testing Archives - Page 25 of 26 - Insights
Skip to Content MayoACCESS MayoLINK...
Prostate Health Index (phi) [Test in Focus] - Insights
Useful For Assessing the patient’s probability of having detectable prostate cancer when totalprostate specific antigen (PSA) concentrations are between
Communiqué Archives - Page 4 of 4 - Insights
Skip to Content MayoACCESS MayoLINK...
Lung Cancer Testing - Mayo Clinic Laboratories
Mayo Clinic Laboratories innovates at the speed of medical advancement, and offers comprehensive options for diagnostic, prognostic, and predictive lung cancer testing.
Hereditary peripheral neuropathy - Insights
Learn how our test menu can assist in identifying genetic causes across the spectrum of hereditary peripheral neuropathies.
Histiocytic neoplasms - Insights
Learn more about how Mayo Clinic Laboratories’ next-generation sequencing panel for histiocytic neoplasms can help physicians accurately diagnose patients and guide treatment for their patients.
Rapid hereditary breast cancer - Insights
Learn how our rapid breast cancer treatment panel delivers results in 10 to 14 days and detects 11 genes linked to lifetime breast cancer risk.
Learn how reliable laboratory diagnosis of a platelet disorders can impact patients’ and their family members' clinical management and outcomes.
Learn why liquid biopsy testing is a viable alternative to tissue-based biopsy testing for certain patients with cancer.